chr3-33543517-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001365631.1(CLASP2):c.3320C>T(p.Thr1107Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00394 in 1,611,652 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0029 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0040 ( 24 hom. )
Consequence
CLASP2
NM_001365631.1 missense
NM_001365631.1 missense
Scores
1
5
12
Clinical Significance
Conservation
PhyloP100: 7.51
Genes affected
CLASP2 (HGNC:17078): (cytoplasmic linker associated protein 2) Enables cytoskeletal protein binding activity; dystroglycan binding activity; and protein tyrosine kinase binding activity. Involved in several processes, including microtubule cytoskeleton organization; positive regulation of extracellular matrix organization; and regulation of supramolecular fiber organization. Located in several cellular components, including basal cortex; cortical microtubule plus-end; and ruffle membrane. Colocalizes with focal adhesion; kinetochore; and microtubule cytoskeleton. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.007506788).
BP6
Variant 3-33543517-G-A is Benign according to our data. Variant chr3-33543517-G-A is described in ClinVar as [Benign]. Clinvar id is 3056625.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High AC in GnomAd4 at 446 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CLASP2 | NM_001365631.1 | c.3320C>T | p.Thr1107Ile | missense_variant | 32/39 | ENST00000682230.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CLASP2 | ENST00000682230.1 | c.3320C>T | p.Thr1107Ile | missense_variant | 32/39 | NM_001365631.1 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00293 AC: 446AN: 152158Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
446
AN:
152158
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00346 AC: 863AN: 249226Hom.: 4 AF XY: 0.00354 AC XY: 479AN XY: 135212
GnomAD3 exomes
AF:
AC:
863
AN:
249226
Hom.:
AF XY:
AC XY:
479
AN XY:
135212
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00405 AC: 5906AN: 1459376Hom.: 24 Cov.: 28 AF XY: 0.00394 AC XY: 2859AN XY: 726242
GnomAD4 exome
AF:
AC:
5906
AN:
1459376
Hom.:
Cov.:
28
AF XY:
AC XY:
2859
AN XY:
726242
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00293 AC: 446AN: 152276Hom.: 1 Cov.: 32 AF XY: 0.00278 AC XY: 207AN XY: 74458
GnomAD4 genome
AF:
AC:
446
AN:
152276
Hom.:
Cov.:
32
AF XY:
AC XY:
207
AN XY:
74458
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
17
ALSPAC
AF:
AC:
11
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
43
ExAC
AF:
AC:
426
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
CLASP2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 15, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;.;T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D;D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
D;D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;.;N;N;.
REVEL
Benign
Sift
Benign
T;T;.;T;T;.
Sift4G
Benign
T;T;T;T;T;T
Polyphen
0.24
.;B;.;.;.;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at